Influence of CD36 deficiency on heart disease in children

Circulation Journal

Volumn 68, Issue 5, 2004, Pages 435-438

  Teraguchi, Masayuki ^a   Ikemoto, Yumiko ^a   Unishi, Gen ^a   Ohkohchi, Hiroyuki ^a   Kobayashi, Yohnosuke ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

CD36 deficiency; Long chain fatty acid metabolism; Pediatric cardiology

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; CD36 ANTIGEN; DIPYRIDAMOLE; LONG CHAIN FATTY ACID; PREDNISOLONE; STEROID; THALLIUM 201;

ADOLESCENT; ARTICLE; CD36 DEFICIENCY; CONGENITAL HEART DISEASE; FALLOT TETRALOGY; FATTY ACID METABOLISM; FEMALE; FLOW CYTOMETRY; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE CELL; HEART SCINTISCANNING; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HUMAN CELL; HYPERTROPHIC CARDIOMYOPATHY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEPHROTIC SYNDROME; PROTEIN DEFICIENCY; SCHOOL CHILD; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOCYTE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; ANTIGENS, CD36; BLOOD PLATELETS; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FATTY ACIDS; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; INFANT, NEWBORN; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MONOCYTES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 2442666298     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.435     Document Type: Article

References (23)

1. a, involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang 1989; 57: 213-217.
2. Abumrad NA, EI-Maghrabi MR, Amri EZ, Lopetz E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J Biol Chem 1993; 268: 17665-17668.
3. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: A review of its role in adherence, signal transduction and transfusion medicine. Blood 1992; 80: 1105-1115.
4. Greenwalt DE, Scheck SH, Rhinehart-Jones T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Invest 1995; 96: 1382-1388.
5. Tanaka T, Sohmiya K, Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 1997; 29: 121-127.
6. Nakamura T, Sugihara H, Inaba T, Kinoshita N, Adachi Y, Hirasaki S, et al. CD36 deficiency has little influence on the pathophysiology of hypertrophic cardiomyopathy. J Moll Cell Cardiol 1999; 31: 1253-1259.
7. a, on platelet membrane glycoprotein IV. Blood 1990; 75: 684-687.
8. Teraguchi M, Ohkohchi H, Ikemoto Y, Higashino H, Kobayashi Y. CD36 deficiency and absent myocardial iodine-123-(R,S)-15-(p-iodophenyl)-3-methylpentadecanoic acid uptake in a girl with cardiomyopathy. Eur J Pediatr 2003; 162: 264-266.
9. World Health Organization/International Society and Federation of Cardiology. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841-842.
10. Teraguchi M, Ikemoto Y, Kobayashi Y. Effective disopyramide treatment in a boy with mid-ventricular hypertrophic obstructive cardiomyopathy. Circ J 2002; 66: 709-711.
11. Knapp FF, Ambrose KR, Goodman MM. Radioiodinated methylbranched fatty acids for cardiac studies. Eur J Nucl Med 1986; 12: S39-S44.
12. Yasui H, Chiba H, Fujiwara H, Morimoto M, Abe K, Yoshida S, et al. Phenotype-genotype correlation in CD36 deficiency types I and II. Thromb Haemost 2000; 84: 436-441.
13. Walker AM, Benson LN, Wilson GJ, Arbus GS. Cardiomyopathy: A late complication of hemolytic uremic syndrome. Pediatr Nephrol 1997; 11: 221-222.
14. Poulton J, Taylor CM, De Giovanni JV. Dilated cardiomyopathy associated with haemolytic uremic syndrome. Br Heart J 1987; 57: 181-183.
15. Fukuichi K, Nozaki S, Yoshizumi T, Hasegawa S, Uehara T, Nakagawa T, et al. Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency). J Nucl Med 1999; 40: 239-243.
16. Hopp L, Gilboa N, Kurland G, Weichler N, Orchard TJ. Acute myocardial infarction in a young boy with nephrotic syndrome: A case report and review of the literature. Pediatr Nephrol 1994; 8: 290-294.
17. Ordonez JD, Hiatt RA, Killebrew EJ, Fireman BH. The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int 1993; 44: 638-642.
18. 2+ current. J Moll Cell Cardiol 1999; 31: 1551-1558.
19. Wemer JC, Sicard RE, Hansen TWR, Solomon E, Cowett RM, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 1992; 120: 286-291.
20. Hosokawa R, Nohara R, Fujibayashi Y, Okuda K, Ogino M, Hata T, et al. Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: Implications for clinical SPECT. J Nucl Med 1997; 38: 1857-1863.
21. Nozaki S, Tanaka T, Yamashita S, Sohmiya K, Yoshizumi T, Okamoto F, et al. CD36 mediates long-chain fatty acid transport in human myocardium: Complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Mol Cell Biochem 1999; 192: 129-135.
22. Coburn CT, Knapp FF, Febbraio M, Beets AL, Silverstein RL, Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 2000; 275: 32523-32529.
23. Kintaka T, Tanaka T, Imai M, Adachi I, Narabayashi I, Kitaura Y. CD36 genotype and long-chain fatty acid uptake in the heart. Circ J 2002; 66: 819-825.